Acute dermatitis is the most common radio-induced side effect during treatment for head and
neck cancer. The use of a wide variety of agents is reported to handle skin toxicity. Our aim …

Purpose The purpose of the study is to evaluate the effects of pharmacological and non-
pharmacological topical controls in the prevention of radiation dermatitis. Methods Relevant …

Background To date, the clinical benefit of topical steroid use has only been demonstrated
for radiation dermatitis induced by 50–60 Gy irradiation in breast cancer. However, these …

Purpose Radiation dermatitis is one of the most common acute toxicities induced by
chemoradiation therapy (CRT) for head and neck cancer (HNC). The benefit of topical …

Acute radiation dermatitis (ARD) commonly develops in cancer patients undergoing
radiotherapy and is often characterized by erythema, desquamation, and pain. A systematic …

Background/Aim: Head and neck cancer is a major malignancy worldwide. The treatment
strategy for head and neck cancer usually involves radiotherapy. The main side effect of …

Radiotherapy is one of the treatment methods available for cancer patients. More than half of
all cancer patients treated with radiotherapy will experience radiodermatitis during their …

Purpose We assessed the role of topical betamethasone as a prophylactic agent in patients
receiving radiation for head and neck malignancies. Methods and Materials This …

Background Radiodermatitis (RD) is a common side effect during radiotherapy. Various
topical agents have been tried to be applied on RD. However, the efficiency of topical agents …

Background The aim of the present trial is to investigate a new option of skin protection in
order to reduce the rate of grade≥ 2 skin toxicity in patients receiving radiotherapy alone or …